| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |